Exercise Capacity, Heart Rate Response Predict CAD Outcomes

This article originally appeared here.
Share this content:
Exercise Capacity, Heart Rate Response Predict CAD Outcomes
Exercise Capacity, Heart Rate Response Predict CAD Outcomes

MONDAY, Nov. 9, 2015 (HealthDay News) -- Exercise capacity (EC) and heart rate responses to exercise are effective predictors of short-term outcome among patients with stable coronary artery disease (CAD), according to a study published in the Nov. 15 issue of The American Journal of Cardiology.

Antti M. Kiviniemi, Ph.D., from University of Oulu in Finland, and colleagues evaluated exercise testing in 1,531 patients with angiographically documented stable CAD who were treated with β-blockers. Age- and gender-adjusted EC, maximal chronotropic response index (CRI), and two-minute post-exercise heart rate recovery (HRR) were calculated. The composite primary end point was cardiovascular deaths and hospitalization due to heart failure over a two-year follow-up. An exercise test risk score was also calculated.

The researchers found that, independent of each other, abnormal EC, CRI, and HRR predicted the primary end point, involving 4.5-, 2.2-, and 6.2-fold risk, respectively. Compared to patients with a low-risk exercise test score, patients with intermediate and high exercise test risk scores had 11.1-fold (P = 0.002) and 25.4-fold (P < 0.001) adjusted risk for the primary end point, respectively. The established risk model had enhanced discrimination by integrated discrimination index and reclassification by categorical and continuous net reclassification index (P < 0.001 for all) with the addition of the exercise risk score.

"The composite index of EC and heart rate responses to exercise and recovery is a powerful predictor of short-term outcome in patients with stable CAD," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »